This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2019 Jul;30(8):769-778.

doi: 10.1177/0956462419839852. Epub 2019 May 12.

Cost of antiretroviral treatment for HIV patients in two centres of North India

Atul Sharma¹, Shankar Prinja¹, Aman Sharma², Aditi Gupta¹, Sunil K Arora³

Affiliations

Affiliations

¹ 1 School of Public health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
² 2 Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
³ 3 Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

PMID: 31081489
DOI: 10.1177/0956462419839852

Cost of antiretroviral treatment for HIV patients in two centres of North India

Atul Sharma et al. Int J STD AIDS. 2019 Jul.

. 2019 Jul;30(8):769-778.

doi: 10.1177/0956462419839852. Epub 2019 May 12.

Authors

Atul Sharma¹, Shankar Prinja¹, Aman Sharma², Aditi Gupta¹, Sunil K Arora³

Affiliations

¹ 1 School of Public health, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
² 2 Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
³ 3 Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

PMID: 31081489
DOI: 10.1177/0956462419839852

No abstract available

Keywords: AIDS; Cost; HIV; India; antiretroviral therapy.

PubMed Disclaimer

Similar articles

Cost implications of HIV retesting for verification in Africa.
Lasry A, Kalou MB, Young PR, Rurangirwa J, Parekh B, Behel S. Lasry A, et al. PLoS One. 2019 Jul 1;14(7):e0218936. doi: 10.1371/journal.pone.0218936. eCollection 2019. PLoS One. 2019. PMID: 31260467 Free PMC article.
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy.
Freedberg KA, Kumarasamy N, Losina E, Cecelia AJ, Scott CA, Divi N, Flanigan TP, Lu Z, Weinstein MC, Wang B, Ganesh AK, Bender MA, Mayer KH, Walensky RP. Freedberg KA, et al. AIDS. 2007 Jul;21 Suppl 4(Suppl 4):S117-28. doi: 10.1097/01.aids.0000279714.60935.a2. AIDS. 2007. PMID: 17620747 Free PMC article.
[Drugs for antiretroviral therapy. The costs of HAART].
Jablonowski H. Jablonowski H. MMW Fortschr Med. 2008 Apr 28;150 Spec No 1:21. MMW Fortschr Med. 2008. PMID: 19024911 German. No abstract available.
Antiretroviral therapy in children--increased benefit from increased complexity.
Cotton MF. Cotton MF. S Afr Med J. 2000 Oct;90(10):985-8. S Afr Med J. 2000. PMID: 11081099 Review. No abstract available.
[Cost of HIV treatment in highly active antiretroviral therapy in Japan].
Kimura H. Kimura H. Nihon Rinsho. 2002 Apr;60(4):813-6. Nihon Rinsho. 2002. PMID: 11968794 Review. Japanese.

See all similar articles

Cited by

Subdividing ART patients and analyzing the medical burden by modeling of CD4 cell count.
Min L, Qunwei W. Min L, et al. J Family Med Prim Care. 2023 Feb;12(2):352-359. doi: 10.4103/jfmpc.jfmpc_1765_22. Epub 2023 Feb 28. J Family Med Prim Care. 2023. PMID: 37091020 Free PMC article.
Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India.
Bahuguna P, Prinja S, Lahariya C, Dhiman RK, Kumar MP, Sharma V, Aggarwal AK, Bhaskar R, De Graeve H, Bekedam H. Bahuguna P, et al. Appl Health Econ Health Policy. 2020 Jun;18(3):393-411. doi: 10.1007/s40258-019-00536-w. Appl Health Econ Health Policy. 2020. PMID: 31741306 Free PMC article.
Process evaluation of health system costing - Experience from CHSI study in India.
Prinja S, Brar S, Singh MP, Rajsekhar K, Sachin O, Naik J, Singh M, Tomar H; CHSI Study Collaborating Investigators; Bahuguna P, Guinness L. Prinja S, et al. PLoS One. 2020 May 13;15(5):e0232873. doi: 10.1371/journal.pone.0232873. eCollection 2020. PLoS One. 2020. PMID: 32401763 Free PMC article.
Cost-effectiveness analysis of 'test and treat' policy for antiretroviral therapy among heterosexual HIV population in India.
Singh M, Sharma A, Bahuguna P, Jyani G, Prinja S. Singh M, et al. Indian J Med Res. 2022 Jun;156(6):705-714. doi: 10.4103/ijmr.IJMR_806_20. Indian J Med Res. 2022. PMID: 37056069 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information